Retinal vein occlusion market players and analysis by type, by condition, diagnosis, treatment, end user - forecast till 2030. The global retinal vein occlusion market is expected to rise at a CAGR of 15.56% over the forecast period from 2022 to 2030, according to the latest research report from Market Research Future (MRFR). The global retinal vein occlusion market is mainly driven by the growing awareness about the disease, the growing prevalence of the disease, including the rising prevalence of diabetes, which is a major risk factor for the disease, and the growing efforts being taken by market players to come up with effective remedies for the disease.
The condition known as retinal vein occlusion occurs when clots or other obstructions form in the veins that carry blood away from the retina. The cycle of blood moving through the extremely fragile area is disrupted and blood flow is restricted as a result. As the area around the corneas and the eyes is extremely sensitive to even the slightest perturbations, this could result in vision loss. One of the most frequent causes of visual loss in the globe is retinal vein occlusion. Over the course of the forecast period, this is anticipated to propel the worldwide retinal vein occlusion market at a solid development rate. The rising prevalence of diabetes is also likely to act as a key driver for the global retinal vein occlusion market, as having diabetes considerably increases the risk of getting a retinal vein occlusion.
The increasing focus of consumers on ophthalmic care is likely to be a key factor in the global retinal vein occlusion market’s growth over the forecast period. While ophthalmic care has always been important, modern methods and processes are making it even more refined and sophisticated, leading to it becoming ever more important within the healthcare sector. The increasing sophistication of the ophthalmology sector could also act as a key driver for the retinal vein occlusion market, as this could lead to the creation of more advanced, innovative solutions to the disease.
Competitive Analysis:
The global retinal vein occlusion market players include Allergan, Bristol-Myers Squibb, Ellex Medical Lasers, IRIDEX Corporation, Quantel Medical Inc., ZEISS, Sanofi Aventis, Alimera Sciences, Icon Biosciences, Genentech Inc., Johnson Johnson Services Inc., Pfizer Inc., Aerpio Therapeutics Inc., Annexin Pharmaceuticals AB, AstraZeneca, Teva Pharmaceutical, Ranbaxy Pharmaceuticals, Suzuken Co. Ltd., Fovea Pharmaceuticals SA, Valeant Pharmaceuticals, Lumenis, Topcon Medical Systems Inc., Novartis, GlaxoSmithKline plc, Regeneron Pharmaceuticals, and Bayer.
Segmentation:
The global retinal vein occlusion market is segmented on the basis of type, condition, diagnosis, treatment, and end user.
On the basis of type, the retinal vein occlusion market is segmented into branch retinal artery occlusion and central retinal vein occlusion.
On the basis of the condition, the retinal vein occlusion market is segmented into non-ischemic and ischemic. The non-ischemic segment held a majority share of more than 62% in the global retinal vein occlusion market in 2016.
Based on diagnosis, the market is segmented into optical coherence tomography (OCT), fundoscopic examination, fluorescein angiography, and others. Fundoscopic examination is the leading segment of the global retinal vein occlusion market by diagnosis.
On the basis of treatment, the retinal vein occlusion market is segmented into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation, and others.
On the basis of end use, it is segmented into hospitals and clinics, research academics centers, and others.
Regional Analysis:
The Americas dominate the global retinal vein occlusion market due to the overall higher level of technology present in the medical establishments in the region, the high disposable income of consumers in the region, and the growing prevalence of retinal vein occlusion in the region. The growing geriatric population in North America and the strong research sector in the region is also a key factor in the growth of the retinal vein occlusion market in the Americas.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
